38 research outputs found

    Dietary Effects on Behavior and Performance for Children with Autism Spectrum Disorder

    Get PDF
    With autism spectrum disorder (ASD) becoming more prevalent, the more we are understanding the manifestations correlated with this disorder; one of which being the dietary issues that are common with those with ASD. This is an important topic to discuss with those with ASD, parents and family members of someone with ASD, and medical providers. To further investigate this topic, this paper will highlight background information about what ASD is, what gastrointestinal issues those with ASD typically have, dietary approaches that are commonly used, and the role that nutrition and diet plays for occupational therapists helping to treat those with ASD.B.A. (Bachelor of Arts

    Ritorno allo sport dopo lesione del legamento collaterale mediale in uno sciatore agonista: case report

    No full text
    Introduzione: la lesione del legamento collaterale mediale è la più frequente lesione legamentosa del ginocchio. È causata da uno stress in valgo e rotazione tibiale esterna ed è uno degli infortuni che si verificano con maggior frequenza nello sci alpino. In questo case report, si descrive un trattamento conservativo suddiviso in 5 fasi. Il Test isocinetico e il Movement Analysis Test vengono proposti come misure di outcome e come criterio per il return to sport in sicurezza. Presentazione del caso: un ragazzo con lesione di 2° grado del LCM subita durante una gara sciistica ha svolto 5 sedute settimanali della durata di circa tre ore per 8 settimane. La suddivisione in 5 fasi comprende: fase 1 - controllo dolore e flogosi, 2 - recupero articolarità, 3 - recupero forza e resistenza, 4 - recupero coordinazione, equilibrio e prevenzione del re-infortunio, 5 - recupero delle gestualità sport-specifica. Al termine della fase 3 è stato eseguito il Test isocinetico per verificare lo stato della forza dell’arto inferiore. Nella 4° fase è stato affrontato un training neuromotorio allo scopo di ridurre i fattori di rischio biomeccanici. Il test MAT ha valutato la qualità del movimento ed è stato eseguito all’inizio e al termine della fase 4. Entrambi i test sono stati ripetuti dopo 6 mesi per verificare la ritenzione a lungo termine. Inoltre, sono state somministrate scale per la valutazione della funzionalità del ginocchio e della kinesiofobia. Conclusioni: l’intervento riabilitativo proposto si è dimostrato valido. Il Test isocinetico ha mostrato il recupero della forza massima e della resistenza dell’arto infortunato. Il MAT ha invece accertato i miglioramenti nella qualità del movimento. Tali test funzionali si sono rivelati strumenti valutativi idonei. Il paziente è tornato alla pratica sportiva in sicurezza e non ha subito infortuni al ginocchio nei mesi seguenti. Il follow-up eseguito a distanza di 6 mesi ha certificato l’efficacia dell’intervento a lungo termine

    The role of the mitochondrial fission proteins Drp1 and Fis1 in the myeloid lineage

    No full text
    reservedMitochondria have recently been found to transcend their traditional role as ‘cellular powerhouses’ to emerge as central hubs for cellular metabolism and signaling. Indeed, mitochondria are involved in several cellular processes, including autophagy, apoptosis, cell proliferation and differentiation, and immune response regulation. Moreover, mitochondria are remarkably dynamic organelles as their morphology is constantly reshaped in perpetual cycles of fusion and fission, comprehensively referred to as ‘mitochondrial dynamics’. Mitochondrial fission is primarily enacted by dynamin-related protein 1 (Drp1), a cytosolic large GTPase that is actively recruited to the outer mitochondrial membrane (OMM) upon fission. In mammals, Drp1 recruitment relies on four binding partners located on the OMM: mitochondrial fission factor (Mff), mitochondrial dynamics proteins of 49 kDa and 51 kDa (MiD49 and MiD51), and mitochondrial fission 1 protein (Fis1). As opposed to Drp1, which has been extensively characterized as a master regulator of mitochondrial fission and implicated in several human pathologies, the role of Fis1 in mammalian mitochondrial fission and pathophysiology has remained controversial, with studies being limited to in vitro models and only recent evidence positioning Fis1 as a key factor in mitophagy, i.e. the process of selective degradation of mitochondria by autophagy. Recently, Fis1 has been implicated in acute myeloid leukemia (AML), a clonal malignancy of the myeloid lineage. Specifically, Fis1 appears to contribute to disease pathogenesis and progression by sustaining the function and the stem-like properties of leukemia stem cells (LSCs), a tumor cell subpopulation that drives the disease by replenishing the proliferating tumor cells (myeloblasts). Indeed, Fis1 is overexpressed in LSCs and seems to support their function through mitophagy. Therefore, we set out to investigate the physiological relevance of mitochondrial fission in the myeloid lineage by resorting to bone marrow-derived macrophages (BMDMs) from myeloid-specific Drp1 and Fis1 conditional knock-out mice, with the aim to unravel new molecular mechanisms that may potentially underlie AML development.Mitochondria have recently been found to transcend their traditional role as ‘cellular powerhouses’ to emerge as central hubs for cellular metabolism and signaling. Indeed, mitochondria are involved in several cellular processes, including autophagy, apoptosis, cell proliferation and differentiation, and immune response regulation. Moreover, mitochondria are remarkably dynamic organelles as their morphology is constantly reshaped in perpetual cycles of fusion and fission, comprehensively referred to as ‘mitochondrial dynamics’. Mitochondrial fission is primarily enacted by dynamin-related protein 1 (Drp1), a cytosolic large GTPase that is actively recruited to the outer mitochondrial membrane (OMM) upon fission. In mammals, Drp1 recruitment relies on four binding partners located on the OMM: mitochondrial fission factor (Mff), mitochondrial dynamics proteins of 49 kDa and 51 kDa (MiD49 and MiD51), and mitochondrial fission 1 protein (Fis1). As opposed to Drp1, which has been extensively characterized as a master regulator of mitochondrial fission and implicated in several human pathologies, the role of Fis1 in mammalian mitochondrial fission and pathophysiology has remained controversial, with studies being limited to in vitro models and only recent evidence positioning Fis1 as a key factor in mitophagy, i.e. the process of selective degradation of mitochondria by autophagy. Recently, Fis1 has been implicated in acute myeloid leukemia (AML), a clonal malignancy of the myeloid lineage. Specifically, Fis1 appears to contribute to disease pathogenesis and progression by sustaining the function and the stem-like properties of leukemia stem cells (LSCs), a tumor cell subpopulation that drives the disease by replenishing the proliferating tumor cells (myeloblasts). Indeed, Fis1 is overexpressed in LSCs and seems to support their function through mitophagy. Therefore, we set out to investigate the physiological relevance of mitochondrial fission in the myeloid lineage by resorting to bone marrow-derived macrophages (BMDMs) from myeloid-specific Drp1 and Fis1 conditional knock-out mice, with the aim to unravel new molecular mechanisms that may potentially underlie AML development
    corecore